Registered outcomes18

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 18 of 18

List	Outcome	Time frame	Description
Primary	Change in maximal inspiratory pressure (MIP)	Baseline and Week 4 (end of the intervention).	Maximal inspiratory pressure (MIP) will be measured using a device with a respiratory pressure measurement function and expressed in cmH2O. Change will be calculated as the Week 4 value minus the baseline value.
Primary	Change in Maximal Expiratory Pressure (MEP)	Baseline and Week 4 (end of the intervention).	Maximal expiratory pressure was measured from total lung capacity against an occluded airway using a digital respiratory pressure meter (MicroRPM) and expressed in cmH2O. Change was calculated as Week 4 minus baseline.
Secondary	Change in forced vital capacity (FVC)	Baseline and Week 4 (end of the intervention).	Forced vital capacity (FVC) will be measured by spirometry and expressed in liters. Change will be calculated as the Week 4 value minus the baseline value.
Secondary	Change in Forced Expiratory Volume in 1 Second (FEV1)	Baseline and Week 4 (end of the intervention).	Volume exhaled in the first second of a forced exhalation maneuver was measured using spirometry, expressed in liters (L).
Secondary	Change in FEV1/FVC Ratio	Baseline and Week 4 (end of the intervention).	The ratio of forced expiratory volume in 1 second to forced vital capacity was assessed using spirometry, expressed as a percentage (%).
Secondary	Change in Slow Vital Capacity (SVC)	Baseline and Week 4 (end of the intervention).	Vital capacity measured during relaxed, unforced breathing using spirometry, expressed in liters (L).
Secondary	Change in Maximal Voluntary Ventilation (MVV)	Baseline and Week 4 (end of the intervention).	Maximal volume of air ventilated over a 12-second sprint breathing protocol was extrapolated to liters per minute (L/min).
Secondary	Change in Seated Medicine Ball Throw Distance	Baseline and Week 4 (end of the intervention).	Upper body explosive power was measured by throwing a 3 kg medicine ball overhead from a seated position with the back supported against a wall. The maximum distance achieved across three trials was recorded in centimeters (cm).
Secondary	Change in 30-Second Modified Push-Up Repetitions	Baseline and Week 4 (end of the intervention).	Upper body muscular endurance was evaluated by counting the maximum number of correctly executed push-up repetitions performed within 30 seconds.
Secondary	Change in 1-Minute Sit-Up Repetitions	Baseline and Week 4 (end of the intervention).	Abdominal muscular endurance was evaluated by recording the maximum number of correctly executed sit-up repetitions completed in 60 seconds.
Secondary	Change in 1-Repetition Maximum (1RM) Bench Press Strength	Baseline and Week 4 (end of the intervention).	Maximal upper body dynamic strength was assessed via 1RM barbell bench press test protocol, expressed in kilograms (kg).
Secondary	Change in 1-Repetition Maximum (1RM) Back Squat Strength	Baseline and Week 4 (end of the intervention).	Maximal lower body dynamic strength was determined using a standard 1RM barbell back squat protocol, expressed in kilograms (kg).
Secondary	Change in Isometric Hand Grip Strength	Baseline and Week 4 (end of the intervention).	Isometric hand grip strength was assessed using a Takei hand dynamometer for dominant and non-dominant hands, recorded in kilograms (kg).
Secondary	Change in Isometric Back and Leg Strength	Baseline and Week 4 (end of the intervention).	Isometric back and leg strength were evaluated using a Takei digital back-and-leg dynamometer, recorded in kilograms (kg).
Secondary	Change in Vertical Jump Height	Baseline and Week 4 (end of the intervention).	Explosive lower extremity power was evaluated via vertical jump test using a jump meter (KK 5406 Jumpmeter). The best attempt was recorded in centimeters (cm).
Secondary	Change in Single Leg Hop Performance and Limb Symmetry Index	Baseline and Week 4 (end of the intervention).	Functional lower extremity performance was measured using single-leg hop test protocols (single hop, triple hop, crossover hop, and side hop). Maximum distance was recorded in cm, and the Limb Symmetry Index (LSI, %) was calculated.
Secondary	Change in Anaerobic Peak and Mean Power (Wingate Test)	Baseline and Week 4 (end of the intervention).	Anaerobic power was evaluated using a 30-second all-out Wingate test on a Monark 894E cycle ergometer against a resistance of 7.5% body weight, expressed in Watts (W).
Secondary	Change in Estimated Maximal Oxygen Consumption (VO2max)	Baseline and Week 4 (end of the intervention) .	Aerobic capacity was evaluated using the Bruce Treadmill Test protocol. The test began on a motorized treadmill at 2.74 km/h and a 10% incline, with speed and incline increasing every 3 minutes until volitional exhaustion. Total test duration (T, in minutes) was recorded, and VO2max was estimated using the standardized regression equation: VO2max = 14.8 - (1.379 \* T) + (0.451 \* T\^2) - (0.012 \* T\^3), expressed in mL/kg/min. Change was calculated as Week 4 minus baseline.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07887282/registered

API reference For AI assistants